Leading Independent Proxy Advisory Firm Gives Full Endorsement to Sylogist-Endorsed Nominees, Rejects OneMove's Case

(TSX: SYZ) ("Sylogist" or the "Corporation"), a leading public sector SaaS company, is pleased to announce that leading ...
The Manila Times

Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort

Detailed data for the gedatolisib triplet and doublet regimens will be presented at a late-breaking abstract oral session at the 2026 ASCO Annual Meeting ...